Dr. Javier Castillo serves The Mount Sinai Hospital as Director of the Hispanic Heart Center. In addition, Dr. Castillo is the Executive Director of the Mitral Foundation and the International Director of the Structural Heart Disease Program at Universidad Complutense in Madrid, Spain.
Dr. Castillo received his medical education at Universitat Rovira I Virgili and pursued further postgraduate education at Mayo Clinic. He then completed his internship and residency in cardiothoracic surgery at The Mount Sinai Hospital and the Icahn School of Medicine at Mount Sinai. In addition, Dr. Castillo completed a research fellowship under Professor David H. Adams in the Department of Cardiovascular surgery at the Icahn School of Medicine at Mount Sinai.
As a surgeon scientist, Dr. Castillo has consistently delivered excellent leading work in different areas including experimental animal research and outcome analysis in cardiothoracic surgery. His research has been presented in the most prestigious scientific conferences and has contributed to advancing the understanding and management of heart valve disease. Dr. Castillo is an author on over 100 peer-reviewed publications and serves on the Editorial Boards of several medical journals and textbooks. He has authored over 25 book chapters on the surgical management of mitral valve disease for the top textbooks in the cardiovascular field including Hurst’s the Heart, Braunwald’s Heart Disease, Sabiston and Spencer Surgery of the Chest or Cardiac Surgery in the Adult. Dr. Castillo is a much sought-after international speaker, particularly in Latin America, and currently plays a leading role in the organization of Conclave Mitral, one of the world’s largest surgical workshop on valve reconstruction in Spanish. He also serves in an advisory capacity to several industry leaders in cardiovascular surgery and holds several patents.
Dr. Castillo’s clinical interests include all aspects of complex valve disease, with a special emphasis on mitral valve reconstruction, aortic root surgery, multivalve surgery and novel percutaneous valve replacement.